Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05862025` - Evaluation of the Usefulness of Echocardiography in Patients With Staphylococcus Aureus Bacteremia (ET-AUREUS Study).	N/A
Not yet recruiting	`NCT05361135` - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia	N/A
Recruiting	`NCT00622882` - Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia	N/A
Recruiting	`NCT06168474` - Evaluating Simplified Layered Consent for Clinical Trials	N/A
Completed	`NCT03163446` - Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia	Phase 2
Not yet recruiting	`NCT06336824` - Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia	Phase 3
Completed	`NCT02357966` - A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus	Phase 1/Phase 2
Recruiting	`NCT04886284` - Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia	Phase 2
Terminated	`NCT03089697` - Phase IIa Clinical Study of N-Rephasin® SAL200	Phase 2
Recruiting	`NCT03514446` - Seven Versus Fourteen Days of Treatment in Uncomplicated Staphylococcus Aureus Bacteremia	Phase 4
Withdrawn	`NCT03761953` - Oritavancin for Staphylococcus Aureus Infections in Opioid Users	Phase 4
Recruiting	`NCT06249451` - Staphylococcus Aureus Bacteraemia (SAB)-Support-Study	N/A
Recruiting	`NCT02098850` - Staphylococcus Aureus Bacteraemia in Adults	N/A
Completed	`NCT01701219` - Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia	Phase 4
Recruiting	`NCT05137119` - Staphylococcus Aureus Network Adaptive Platform Trial	Phase 4
Completed	`NCT03908086` - Bloodstream Infections in Patients With Rheumatoid Arthritis
Terminated	`NCT04160468` - Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase	Phase 3
Completed	`NCT03138733` - Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia	Phase 3
Completed	`NCT02476487` - The Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus Bacteremia	N/A
Recruiting	`NCT05184764` - Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia	Phase 1/Phase 2

NCT number	NCT01971762
Study type	Observational
Source	Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
Contact
Status	Completed
Phase	N/A
Start date	April 2011
Completion date	January 2012

Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular Epidemiology

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms